PATENT CLAIM ANALYSIS

Application Number: 16221274
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "300000"]

Abstract:
The invention relates to compounds of formula (I): wherein Q, A 1 , A 2 , A 3 , A 5 , A 6 , A 7 , A 8 , R 4a , R 4b  and R 5  are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are useful in the treatment of diseases and disorders in which undesired or over-activation of NF-kB signaling is observed.

Claim (Index 24):
The compound of  claim 2 , or a stereoisomer, tautomer, solvate, prodrug or salt thereof, wherein each R 4a  and R 4b  is H.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 98.0
- Lexical Diversity: 1.59184
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16220963', '15314938', '15026250', '14378975', '15904143']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7506537275791456
- 35 USC 102 Novelty (BERT): 0.5876527469427462
- Combined Prediction Score: 0.7343536295155056
- Mean Citation Score: 329.27391
- Max Citation Score: 485.14618
- Similarity Product: 417.2270519204952

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test